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ublished by Elsevier Inc.Long-Term Survival and Amputation Risk in Thromboangiitis Obliterans (Buerger’s Disease)
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ao the Editor: Thromboangiitis obliterans (TAO), or Buerger’s
isease, is an unusual tobacco-associated vasculopathy that is
haracterized by segmental thrombotic occlusions of small- and
edium-sized arteries of the extremities. The long-term risks of
mputation and death in TAO have not been described in detail.
he incidence in North America is 8 to 11.6 per 100,000 persons
er year, estimated from referral populations (1). Olin et al. (2)
eported a study of 112 patients with TAO that was gathered from
970 to 1987. Most, but not all, of the patients in that study were
iagnosed by histopathology (n  17) or arteriography (n  88).
uring a mean follow-up of 91.6 months, 27% underwent one or
ore amputations. Despite the high morbidity of this illness, life
xpectancy among patients with Buerger’s disease is reported to be
omparable with that of age-matched controls (3).
A vascular medicine-trained physician abstracted the medical
ecords of all patients with TAO registered at Mayo Clinic from
anuary 1, 1976, to December 31, 1999 (n  344). The inclusion
riteria were: age50 years, tobacco use, and objective evidence of
edium or small arterial disease by either angiography (n  107)
r tissue pathology (n  4). Exclusion criteria included any
oncomitant cause for arterial occlusive disease, including proximal
therosclerosis, trauma, entrapment syndromes, diabetes, or con-
ective tissue or thrombotic diseases. Two hundred thirty-three
atients were excluded.
All 111 patients had tests to exclude other causes of arterial
cclusions as follows: erythrocyte sedimentation rate (n 111; 100%),
ntinuclear antibody (n  111; 100%), rheumatoid factor (n  75;
8%), extractable nuclear antigen (n  34; 31%), thrombosis panel
protein C, protein S, antithrombin III and, recently, factor V Leiden
nd prothrombin 20210A gene studies; n  35; 32%), and anticar-
iolipin antibodies (n  22; 20%).
A survey requesting detailed information on amputations,
icotine use, and family medical history was mailed to all surviving
embers of the study population (n 88). A modified Fagerstrom
est for Nicotine Dependence questionnaire (FTND) was used to
scertain the degree of nicotine dependence (4). The FTND is a
ix-item self-reported instrument designed to evaluate the level of
icotine dependence. For former smokers, a modified version of
he FTND with past tense verbs was used to allow collection of
etrospective information. Fifty of 88 patients (57%) completed the
urvey.
In the statistical analysis, continuous variables were compared
sing a Wilcoxon rank-sum test. Categorical variables were com-
ared with a chi-square test. Kaplan-Meier curves were generated
o estimate rates of major and minor amputation and death, and a
wo-sample log-rank test was used to compare the survival expe-
iences between groups (5). The Kaplan-Meier estimate of survival
or patients with TAO was compared with expected survival in the
.S. population (on the basis of age- and gender-specific mortality
ates) using a one-sample log-rank test (6). A Cox proportional
azards model was used to identify patient characteristics (includ-
ng gender, race, treatment, and time-dependent continued to-
acco exposure after diagnosis) that were significantly associated
ith the aforementioned events. Because patients typically expe-
s
hience multiple events (i.e., ulceration, amputation, and death), a
ultiple events extended Cox model also was used (7).
The mean age of the entire TAO cohort was 33  8 years, and
0% were women. The percentage of female subjects increased
rom 32% for the 5-year period from 1976 to 1980 to 50% after
996 (p  0.09 for trend, by Armitage test). The mean follow-up
as 15.6  10.1 years (187 months; range, 6 months to 59 years;
edian, 14.8 years). Risk factors for atherosclerosis included
ypertension (8.1%), hyperlipidemia (46.5%), and a family history
f cardiovascular disease (56.6%). In addition, 63.1% of patients
ith TAO reported current use of tobacco at the time of diagnosis.
hose subjects who completed the survey had a mean Fagerstrom
icotine Dependency Score of 4.8, indicating mild to moderate
ddiction (4).
Treatment variables after diagnosis included the following: use
f antiplatelet agents (46.9%), dihydropyridine calcium channel
lockers (24.3%), alpha-blockers (19.8%), anticoagulants (18.9%),
ther vasodilators (5.4%), statins (5%), transdermal nitrates (4%),
nd angiotensin-converting enzyme inhibitors (0.9%). Forty-two
atients (39%) had sympathectomy, and 13 (12%) had bypass
urgery at the time of or subsequent to diagnosis.
The time to first amputation (any and major) ascertained from
urvey follow-up and chart review is illustrated in Figure 1. Forty
atients underwent first amputations during a median follow-up of
4.8 years (mean follow-up, 15.6 years). The risk was 25% (0.16 to
.33) at 5 years, 38% (0.27 to 0.47) at 10 years, and 46% (0.33 to
.56) at 20 years. Twenty patients underwent first major amputa-
ions, defined as above-the-knee, below-the-knee, or hand ampu-
ation during this time period. The risk of major amputation was
1% (0.05 to 0.17) at 5 years, 21% (0.12 to 0.30) at 10 years, and
3% (0.13 to 0.31) at 20 years.
The effect of tobacco cessation on amputation risk and survival
as assessed by estimating the rates for the interval of continued
obacco exposure and also for the interval of tobacco exposure
essation. Specifically, an individual who has stopped smoking
igure 1. Kaplan-Meier analysis of the rate of first amputation and major
mputation in the thromboangiitis obliterans cohort from time of diagno-
is. Major amputation is defined as a below the knee, above the knee, or
and amputation.
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December 21, 2004:2410–9ould be in the interval of continued tobacco use from the time of
iagnosis until he or she ceased smoking, at which point he or she
ould be placed in the interval of tobacco exposure cessation. In an
nalysis in which each amputation in persons with multiple
mputations was considered a separate event, the amputation rate
as 84.3 (confidence interval 68.4 to 102.7 amputations/person
ear  1000) in the interval of continued tobacco use versus 30.6
confidence interval 17.5 to 49.6 amputations/person year 1000)
n the interval of discontinued tobacco use.
Survival in the TAO cohort was compared with the expected
urvival in the U.S. population on the basis of age- and gender-
pecific mortality rates (Fig. 2). Fifteen of 111 subjects died in a
edian of 14.8 years of follow-up. The average age at death was
2.2 8.9 years. The survival of the TAO cohort was significantly
ower than that in the matched U.S. population (p  0.001 by
og-rank test). In univariate analysis, only older age at diagnosis
nd decade of diagnosis were associated with an increased risk of
eath. The risk of death was nearly identical in those subjects who
ontinued to use tobacco and those who quit. In multivariate
odels, no variables were associated with risk of death.
The present TAO series is the first to report time-dependent
vent rates for major or any amputation and death. Our analyses
ave resulted in several novel observations: The risk of amputation
ontinues in ongoing smokers up to a median of 14.8 years (mean,
5.6 years) after initial diagnosis. The risk of amputation in
igure 2. Observed survival in the thromboangiitis obliterans population
efore and after tobacco cessation compared with the expected survival in
n age- and gender-matched U.S. population (controls). p  0.001 by
og-rank test.in Healthy Elde
ix months’ regular exercise training on serum CRP levels and body
f
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cn contrast to previous studies, we report an excessive late mortality
n patients with TAO compared with the U.S. population (2,3).
Our data are limited in several ways. Not all patients had
ystematic evaluation for thrombophilia and autoimmune disease.
he results of this study may not apply to patients with TAO in
he community. The cause of death is not known for most patients.
he ascertainment of nicotine cessation by chart review and survey
ay not accurately reflect actual smoking cessation. Those with
ild addiction might be more likely than those with severe
ddiction to complete the survey. Finally, a substantial fraction of
atients with TAO who reported smoking cessation may have
ontinued to smoke.
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Effect of Six Months’ Exercise Training on C-Reactive Protein Levels
rly Subjectso the Editor: Nonspecific markers of inflammation such as
-reactive protein (CRP) are now recognized as major risk factors
or cardiovascular events. General population studies have reported
n inverse association between serum CRP levels and self-reported
hysical activity or physical fitness (1,2). These studies suggested
hat regular physical exercise might lower CRP levels by an
nti-inflammatory action. However, an alternative explanation is
hat exercise lowers CRP levels by reducing total or abdominal fat.
e performed a randomized controlled trial to assess the effects ofat measured by dual-energy X-ray absorptiometry (DEXA) in a
ealthy elderly population.
Healthy elderly subjects age 60 to 85 years were recruited from
he general population by newspaper advertisements. The exclu-
ion criteria included inability to undertake an exercise-training
rogram, current illness known to be associated with a systemic
nflammatory response, a history of hypertension or diabetes, any
urrent cardiovascular medication (including aspirin), or any evi-
ence of cardiovascular disease on physical examination, electro-
ardiography, treadmill exercise testing, or echocardiography. The
